184 related articles for article (PubMed ID: 28703780)
21. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
22. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
Boothe DM; Boeckh A; Simpson RB; Dubose K
J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
[TBL] [Abstract][Full Text] [Related]
23. [In vitro antibiotic susceptibility to fluoroquinolones].
Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.
Al-Naqshbandi AA; Chawsheen MA; Abdulqader HH
J Infect Public Health; 2019; 12(3):330-336. PubMed ID: 30522892
[TBL] [Abstract][Full Text] [Related]
25. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
[TBL] [Abstract][Full Text] [Related]
26. New antibiotics for severe ICU-aquired bacterial infections.
Poissy J; Senneville E
Infect Disord Drug Targets; 2011 Aug; 11(4):401-12. PubMed ID: 21679140
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds.
Dubreuil L; Behra-Miellet J; Neut C; Calvet L
Clin Microbiol Infect; 2003 Nov; 9(11):1133-8. PubMed ID: 14616733
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival bacterial flora and antimicrobial susceptibility of captive and free-living sea turtles in Brazil.
Cardoso-Brito V; Raposo ACS; Pires TT; Pinna MH; Oriá AP
Vet Ophthalmol; 2019 May; 22(3):246-255. PubMed ID: 29953719
[TBL] [Abstract][Full Text] [Related]
29. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
[TBL] [Abstract][Full Text] [Related]
30. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Pong A; Thomson KS; Moland ES; Chartrand SA; Sanders CC
J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
[TBL] [Abstract][Full Text] [Related]
31. [Antimicrobial resistance trends in pathogens isolated from nosocomial infections].
Rincón-León HA; Navarro-Fuentes KR
Rev Med Inst Mex Seguro Soc; 2016; 54(1):32-41. PubMed ID: 26820196
[TBL] [Abstract][Full Text] [Related]
32. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Goldstein MH; Kowalski RP; Gordon YJ
Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
[TBL] [Abstract][Full Text] [Related]
33. [Microbial flora and sensitivity to antibiotics in surgical abdominal infection].
Potapov AF
Anesteziol Reanimatol; 2004; (2):52-4. PubMed ID: 15206280
[TBL] [Abstract][Full Text] [Related]
34. The pattern of bacterial isolates and drug sensitivities of infected ulcers in patients with leprosy in ALERT, Kuyera and Gambo hospitals, Ethiopia.
Lema T; Woldeamanuel Y; Asrat D; Hunegnaw M; Baraki A; Kebede Y; Yamuah L; Aseffa A
Lepr Rev; 2012 Mar; 83(1):40-51. PubMed ID: 22655469
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
[TBL] [Abstract][Full Text] [Related]
36. [The appearance of ciprofloxacin resistance in the microbial strains isolated from gynecologic patients].
Shopova E
Akush Ginekol (Sofiia); 1997; 36(1):14-6. PubMed ID: 9289951
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.
Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA;
Diagn Microbiol Infect Dis; 2001; 40(1-2):51-7. PubMed ID: 11448564
[TBL] [Abstract][Full Text] [Related]
38. Microbial keratitis in Waikato, New Zealand.
Pandita A; Murphy C
Clin Exp Ophthalmol; 2011 Jul; 39(5):393-7. PubMed ID: 21176039
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).
Pfaller MA; Flamm RK; Duncan LR; Streit JM; Castanheira M; Sader HS
Diagn Microbiol Infect Dis; 2018 May; 91(1):77-84. PubMed ID: 29395713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]